// App-Quantinova.ai

18938 : Prognostically Important Myocardial Infarctions are Markedly Underreported in Patients Undergoing Percutaneous Coronary Intervention: Insights from CHAMPION PHOENIX

Researchers

Presenter

  • Deepak L Bhatt

Principal Investigators

  • Gregg W Stone

  • Tiepu Liu

  • Simona Skerjanec

  • Jayne Prats

  • Harvey D White

  • Robert A Harrington

  • C. Michael Gibson

  • P. Gabriel Steg

  • Hopital Bichat

  • Christian W Hamm

  • Matthew D Wilson

  • Stacey Mangum

  • Sergio Leonardi

  • Matthew J Price

Medical Centers

  • Brigham and Womens Hospital Heart and Vascular Center, Boston, MA

  • Auckland City Hospital, Auckland, New Zealand

  • Cardiovascular Research Foundation, Orangeburg, NY

  • Duke Clinical Research Institute, Durham, NC

  • Scripps Clinic Torrey Pines, La Jolla, CA

  • Assistance Publique, Hopitaux de Paris, Hopital Tenon, Paris, France

  • Beth Israel Deaconess Medical Center, Boston, MA

  • Kerckhoff Heart Center, Bad Nauheim, Germany

  • The Medicines Company, Parsippany, NJ

  • Fondazione IRCCS Policlinico San Matteo, NICU, Pavia, Italy

Locations

  • Italy

  • Germany

  • United States

  • France

  • New Zealand

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Myocardial infarction

  • Venous thrombosis

  • Coronary Artery Disease

Biomarkers

  • N/A

Drug/Treatment

  • Clopidogrel bisulfate

  • cangrelor

Outcome

  • N/A

Study Design

  • double blind/blinded

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved